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EVALUATION OF TOPICAL ANTI-INFLAMMATORY STEROID 
FORMULATIONS IN AN ARTHUS MODEL OF INFLAMMATION 
MARVIN B. GOLOLUST. PH. .D ., DOUGu.s M. PA.LMER, M .S., AND MA.TTHEW A . AUGUST1NE, PH .D. 
Immunology Section. Department of Pharmacology and Department of Pharmaceutical Research , Squibb Institute for 
M edical Research. Princeton and New Brunswick. New Jersey, U. S. A . 
Formulations of a number of steroids were evaluated after topical application in a reve rsed 
passive Arthus test (RPA) in rabbits . Four 21·chlorosteroids in the same cream base were 
investigated. The p reparations of SQ 18,566 (halcinonide ) and SQ 20.811 showed anti·edema 
activity. but those of SQ 15,361 and SQ 20.589 were less active. Ointment formulations of 
halcinonide also reduced edema in the RPA . These results. cou pled with previously reported 
clinical data. suggest that the RPA might be utilized to distinguish good from poor 
formulations of anti-inflammatory steroids p rior to screen ing tests or clinical trial In 
humans. 
P revious studies by Bagatell and Augustine 11 J 
described the relative effectiveness in the human 
vasoconstrictor and stripped-skin screens of four 
21-chlorosteroid .. applied as tinctures. These in-
vestigators also reported the relati\'e clinical effec-
tiveness of these steroids when applied as 0.1 '1-
cream s. Discrepancies were obser\'ed in the rela· 
live effectiveness of these ste roids when the results 
in the human screen s were compared with the data 
from the clinical trial \1 J. As suggested by the 
physicochemical data \l J. factors that influence 
bioavailability probably account for the obser\'a-
tion that the cream formul ation. although appro-
priate for some of the chlorosteroids. was not 
opt imal for every single one. 
Topical steroids a re screened in the vasoconst ric· 
tor and stripped-skin procedures in humans . These 
tests utilize unformulated. but solubilized (e.g .. in 
et hanol). preparations of ne\\'ly symhesized ste-
roids . In an attempt to 8\'oid some of the difficul-
ties in\'oh'ed in human studies of la rge numbers of 
formulations . we have adapted an animal model of 
inflammation for the testing of formulated topical 
steroids. namely . the reversed passi\'e Arthus skin 
test (RPA I in the rabbit. 
The Arthus lesion. which is generated b~' an 
immu ne rea ction 12J. manifests notable edema. 
Inhibition of thi s edema is rou tinely used in our 
laboratories to detect nonsteroidal ami-inflamma· 
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- Halcinonide (SQ 18.566) is 9a-nuoro-21-chloro-ll/l 
16a .17 a · t ri hyd roxypreJ!n- -I -ene·3.20-d ione.16.1 j ·ace-
ton ide. SQ 15.361 is the ol l . • derivati\'e. SQ 20.589 is the 
.0. I . '. desfluoro de ri\'ative. and SQ 20.811 is the desfluoro 
derivative of halcinonide. 
tory agents 131. Ln the ser ies of experiments pre-
sented here. we obtained data showing that paren· 
LeTal administration of small doses of corticoste· 
roids. such as triamcinolone acetonide and hal· 
cinonide. are effective in this test system. Add i-
tional data suggest a rank order of activities in the 
RPA of the four previously mentioned 21-chloro-
steroids \1 J when they a re applied topically in the 
same formulation. Our data indicate that SQ 
15.361 and SQ 20.589 were less effective topically 
than halcinon ide and SQ 20,811 in anti-edema 
activity . Ointment formulations of halcinonide 
were also effective in the RPA. 
MATERIALS A"iD METHODS 
The Repersed Passive .4.rlhus Skin Test (RPA) 
This test has been described recently 13]. 
Intradermal administration of sterOids. Each rabbit 
received an int ravenous injec tion of 25 m~ of bovine 
serum albumin (BSA ) in 5 ml of saline. followed immedi· 
ately by intradermal injections of 0.2 m\ of rabbit 
antiserum to BSA (Cappel Laboratories. Downinlnown. 
Pa .) mixed with steroid in saline suspension. Each rabbit 
received 6 injections. the same dose of steroid being 
administered to each of 3 si~es and the remaining :1 shes 
serving as controls. The treated and cont rol sites were 
placed alternately. 3 on each side of the midline of the 
back. Inhibition of edema by at least 30~ was conside red 
to be significant. 
Topical application of steroids. A lOO·mg quantity of 
steroid preparation (cream or ointment I was applied 
around each skin injection site, just after the injection of 
antiserum . Four sites per rabbit were used. A separate 
disposable vinyl medical glove (Bard·Parker. Div. of 
Becton. Dickinson and Co .. Rutherford. N.J .) was used 
for the application of each preparation. The steroids were 
rubbed gently on the injPction blebs but n01 on the 
injection sites. i'o occlusive dressings were used. The 
edema volumes were measured as pre\'iously described 
13}. 6 hr after application of the steroid . Brieny. a 
double-fold thickness of skin at the center of each skin 
si te was measured before and after lesions were produced. 
The diameters of the wheals were measured and the 
lesion volumes were calculated using the formula for a 
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cylinder (n rl x .6. thickness) . Separate treatment and 
control groups of animals were utilized; inhibition of 
edema was calculated by comparing the average edema 
volumes of treated and placebo control grou ps. 
Many of the assays were carried out in the winter. 
when t.he rabbits had developed thi ck seasonal hai r coats. 
in each experiment. we included a sizeable number of 
rabbits with coats that did not permit the skin to be 
shaved cleanly; these animals had a thin . uniform layer 
of coarse hair on the back . Although topically applied 
creams or placebos were sometimes not fully absorbed. 
i.e .. some residue remained around the Arthus lesions. we 
could discern no relationship of coarse hair pattern~ to 
the presence of residue or to degree of ant i-edema 
activity. Nor were the responses of rabbits with coarse 
hair patterns obviously different from those of smoot.hly 
shaven rabbits within the same treatment group. 
Statistical significance was ca lculated by the Wilcoxon 
rank sum test. utilizing the table indicated in Dixon and 
Massey [4]. Each treatment group was compared directly 
with the placebo· treated group. 
Our criteria for significant activity in this assay are 
:::: 30% decrease in edema with a p value of ~ 0.05. These 
criteria were applied to each experiment. 
Vasoconstric tor ( Ve ) and Stripped-Skin (55) Assays 
These procedures were performed as previously de· 
scribed [1[. 
Steroids 
Bulk halcinonide (SQ 18.566l. SQ 15. 361. SQ 20.589. 
SQ 20.81 1. and triamcinolone 8cetonide were synt hesized 
at the Squibb lnstitute for Medical Research. 
e ream formulations . Preparations of halcinonide, SQ 
15.361. SQ 20.589. snd SQ 20.811 previously tested in 
humans [1 J consisted of 0.1 gm of steroid. glyceryl 
monostearate. cetyl alcohol. spermaceti. isopropyl pal -
mitat.e. and polysorbate 60, and 60 gm of propylene glycol 
per 100 gm of aqueous cream. 
Ointment formulations . Two 0.1 % halcinonide prep-
arations, designated WP and WPS. were prepared. WP 
consisted of steroid plus a mixture of polyethylene 
glycols (22%) in white petrolatum. v.rpS was a similar 
formulation containing 2 gm of Span 80 per 100 gm of 
ointment. Appropriate ointment placebos were prepared. 
RESULTS 
Sensitivity of RPA . VC. and SS Assays to Locally 
Administered Steroids 
As previously reported 13 J. the RPA ha s been 
utilized in screening nonsteroidal anti-inflamma-
tory agents via the intradermal administration of 
these agents at the skin test sites. During t.hese 
studies. a number of steroids were test.ed and found 
to be effective in suppressing edema. Triamcino-
lone acetonide and halcinonide were evaluated in 
dose- res ponse studies in an atLempt to determine 
t.he smallest amount of each steroid that co uld be 
detected. The results (Tab. I) indicate that each 
steroid. applied in a dose of 0.03 pg per site. caused 
significant inhibition in the R PA test. but did not 
do so at 0.003 pg per site. 
The sensitivity (ha[f-maximal response) of the 
VC and 55 assays to halcinonide (as tinclUre) was 
determined from the data of Bagstell and Augus-
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TABU: I. Dose-response determinations in the RPA test 
of intradermally administered steroids 
Number Dose Mean percent Steroidg of (~g/'~ itf'l decrease in edema~ rabbit!' (Range ) 
Halcinonide 4 300 56 (48- 621 
(SQ 18.5661 
3 30 61 (57 - 66) 
6 0.3 55( 49- 651 
4 0.03 44 (40- 461 
3 0.003 10 ( 5- 141 
Triamcinolone 300 43 
acetonide 
2 3 53 (46- 591 
4 0.03 4:1 (37- 531 
3 0.003 17 ( 9- 281 
g Each animal received the sa me dose or one sleroid in 
3 skin si l.e~ . Three ()ther sit e!> were used as controls. 
b Data are cumulative from 5 experiments. 
tine 11 J 1.0 be about 0.024 and 0.0012 pg per si te. 
respeclivel~'. Since the sensitivit~· of' the RPA test 
to intradermallj.· administered halcinonide was 
similar to that for tinctures of these steroids in the 
VC assay. the possib le use of the RPA for assessing 
the activity of topically applied s teroids in formu -
lation was considered. 
Topical Application of Sieroids in Formulation 
The pre\·iously described O.l C'( cream formula-
tions of hal ci nonide (S Q 18.5661. SQ 15.36 1. S Q 
20.589. and SQ 20.811 [1) were evaluated in a blind 
fashion in the RPA assa~·. The results are indicated 
in Table I!. SQ 20.589 and SQ 15.361 were less 
effective than hal ci nonide and SQ 20.811. The 
placebo cream for the 21-c hlorosteroids did 11 0 t 
cause any significant effect on Arthus edema . In 
summary. halcinonide in 5 of 6 assa~·s and SQ 
20.811 in 2 of' 2 assays demonstrated significant 
activity by our criteria . SQ 20.589 in .4 of 5 assa~·s 
and SQ 15.36 1 in 3 of 3 assa\'s were found to be 
un accepta ble . 
The low activity of SQ 15.361 cream. applied 
topically. raised the poss ibilit y that this steroid 
was inherently inactive in the RPA test . However. 
when applied intradermally. SQ 1.').361 was simi lar 
in potency to halcin onide (Tab. Ill. Experiment 1) . 
Addi tiona[ data obtained at a single dose of 0.3 
pg/site indicated that all four chlorosteroids pos-
sessed anti-edema acti .... ity (Tab. Il l. Experiment 
2). 
In addition. Table TV indicates that topically 
applied ointment rormulations of halcinonide were 
effective in the RPA assay. Appropriate placebos 
we re without effect. 
DISCUSSION 
The present studies demonstrate that certain 
topically appl\ed corticosteroid formulations pos-
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sess anti-edema act ivily in the reversed passive 
Arthus test (RPA) in rabbits. Our resu lts are 
consistent with the findings of Bagatell and Augus-
tine III that SQ 15.361 in a 0.1% cream formula-
tion was inferior to halci nonide when both were 
compared in a limited clinical trial. However. SQ 
20.589 and SQ 20.81 I. con trary to our RPA data. 
tended to be equally effective in that clinical trial. 
The relative degrees of inhibition in the RPA 
ca used by each of the four chlorosteroid creams 
show a rank-order correlation with the solubility of 
the compound s in the solvent com partment of the 
vehicle . Hal cinonide and SQ 20.81 I. the most 
soluble of the fou r steroids in 60 '!! propylene glycol 
11 J. were the most active when topically applied in 
the RPA . However. use of the method of Katz and 
Shaikh 15] failed to demonstrate a linear rela tion-
ship between the product of steroid solubility and 
partition coefficient and the logarithm of the 
biologic response. 
The observations on SQ 15.361 are of interest. 
This steroid. as an ethanolic solution. showed good 
topical act ivi ty in t he human \'asoconst rictor and 
stripped-skin tests . SQ 15.361 as a cream was less 
effective clinically than halcinonide 11]. presum -
TAB1.E II . Effe('t .\ of topic-ali,' applied 21-chloro.,t erOld 
('ream formulat/ofl.~ In the RPA in rabbit ., 
Expe rIment 51 erOldQ ~ Mean percen' decrease in edema 
Ha lci nonide 401.0011' 
Q 1.1.161 1.11.161 
SQ 20 . .189 3-31.0211 
2 Haldnonidp 4 (,0011 
SQ 1.1.:\61 201.0211 
Halc.nonidpl> 41 1.0021 
SQ ~0.811 40 1.00 11 
Q 20 .. 189 16 !.I61 
4 SQ 18.566' 31 (.onl 
Haklnonidc 421.0081 
SQ 1.1 .. 161 22 (.20) 
SQ 20 . .189 101.471 
Hakinonide :<8 1.09) 
SQ ~O-,)89 2;(,12) 
6 SQ ZO.8tt 5.1 \.Q()4) 
Hald nonide 43(.0011 
SQ 20.089 7 1.29) 
P Six animals per treatment group or placebo ~roup 
were used . One hundred mg ofO.l f"( ('ream were applied 
to each of 4 skin sites per rahbit. 
/I Those compounds indicated by SQ numbers were 
evaluated in a blind fas hion. In Experiment #3. hakino-
nide was tested in hoth a blind and open fashion . 
.. p value vs pls('ebo g:roup (rank su m test). 
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TARI.E III. Intra dermal activity of four 2 1-chlorosterolds 
in the RPA in ra bbit.'t 
Dos. Percent Experiment Steroid- flAf! !SIt(') decrease in edema' 
SQ 15.161 3.0 40 
0.3 40 
0.03 30 
0.003 0 
Halcinonide 0.:\ 50 
0.03 50 
0.003 17 
2 Halcinonide O.~ 59: 47 
Q 15 .. 161 0. :) 36:38 
'Q 20.589 0 .3 45:61 
SQ 20.811 0.3 49: 51 
Q Each animal received one compound at the indicated 
dose in each of 3 s kin site~ . Three other ~ites were used 8S 
ennl rob .. 
" Each value represents a si ngle animal. 
T ""\1.[ i\' . Effeels of topically applied hafcinonide 
ointment formulation. .. in th e RPA in ra bbits 
EXIJefiment 
Gr.DUp Mean 
size Sleroido percent (Treated. denease 
Control) in edema 
fl.;) Halcinonide 55 (,004)' 
(0. 1 <;;)- II'P 
2 4.4 Halcinonide 361.0571 
(0 .1 'I I· II'P 
D ~o si~nificant placebo effects were observed . 
"p vslue \'~ placebo ~roup Irank sum test) . 
ably because of its poorer vehicle olubili ty. The 
solubility of SQ 15.361 in the cream vehicle is only 
one-tent h that estimated for halcinonide , This is 
based on solubility in 60 "< propylene glycol. the 
concent ration used in the cream \'ehicle, Howe\'er, 
the oill",ater partition coefficients for SQ 15.361 
and halcinoni de from the 60 '; propylene glycol 
sol\'ent into isopropyl m~'ristate are simila r and 
favor the lipid phase 11]. If the stratum corneum is 
con idered as a lipid barrier. then greater release of 
the steroid from its \'ehicle int o the st ratum 
corneum should reflect the part ition coefficients, 
Since the coefficient s are similar for the two 
steroids. solubili l ~' in the formu lation \'ehicle ap-
pears to be more important. These data also 
suggest the value of a study of formulations that 
might enhance the topical acti\'ity of a steroid both 
in the RPA and the clinic. 
Evaluation by the RPA of\'arious concent rations 
of a steroid is one approach to gai ning fu rther 
inform ation about the topical effectiveness of that 
steroid. Because the physicochemical propertie~ of 
a steroid in a particular formulation. e,g .. its 
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solubility. may vary with concentration, differ-
ences in topical potency may reflect not only 
changes in steroid concentration. but the physico ~ 
chemical st.ate of the steroid at these concentra-
tions . 
The pot.ential usefulness of the RPA model has 
been demonstrated not only for cream fo rmula-
tions (Tab. Il) but also for ointment preparat ions 
of haleinonide (Tab . IV). Further studies are 
needed to correlate topical activities of formula -
tions of other novel steroids in the RPA with those 
in the screening tests and clinical trials in humans. 
The authors do not wish to imply that the physi-
cochemical properties of rabbit. skin and human 
skin are comparable . but such studies would help 
to define the degrees of similarity of the two 
species . It is probably not possible to discriminate 
by the RPA between preparations of the same or 
different steroids that differ only slightly in effec-
tiveness. However. our datB do suggest that it is 
possible to eliminate obviously poor form ulation s 
Vol. 66. No.3 
from further evaluation in the more difficult, and 
perhaps no more informative. clini cal trials . 
The authors thank Mr. W. F. Schreiber and Mr. A. 
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